Literature DB >> 15110324

The major allele of the alanine:glyoxylate aminotransferase gene: seven novel mutations causing primary hyperoxaluria type 1.

Marion B Coulter-Mackie1, Derek Applegarth, Jennifer R Toone, Howard Henderson.   

Abstract

We describe 7 novel mutations occurring on the major allele of the human AGT gene in patients with primary hyperoxaluria type 1, an autosomal recessive disease resulting from a deficiency of the liver peroxisomal enzyme alanine:glyoxylate aminotransferase (AGT; EC 2.6.1.44). These mutations include 3 small deletions, 570delG, 744delC, and 983_988del, two splice junction mutations, IVS7-1G-->C and IVS8+1G-->T, and two nonsense mutations, R111X and W251X. We have also identified recurrences of previously identified reported mutations, 679-(IVS6+2)delAAgt, IVS8-3C-->G and 33insC. Deletion mutation 679-(IVS6+2)delAAgt has now been identified in a second Chinese patient and may be specific to that population. In contrast, 33insC has been found in patients of varying ethnic and racial backgrounds; a single vs multiple origin for this mutation is thus an intriguing question. It also appears to occur at a high frequency on the major allele. Five of the novel mutations were detected in patients who were compound heterozygotes for one of the common mis-targeting mutation, G170R or F152I, while the other two mutations occurred in the same patient.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15110324     DOI: 10.1016/j.ymgme.2004.02.001

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  8 in total

Review 1.  Primary hyperoxaluria type 1: still challenging!

Authors:  Pierre Cochat; Aurélia Liutkus; Sonia Fargue; Odile Basmaison; Bruno Ranchin; Marie-Odile Rolland
Journal:  Pediatr Nephrol       Date:  2006-06-30       Impact factor: 3.714

2.  Identification of 8 novel gene variants in primary hyperoxaluria in 21 Chinese children with urinary stones.

Authors:  Lei He; Guofeng Xu; Xiaoliang Fang; Houwei Lin; Maosheng Xu; Yongguo Yu; Hongquan Geng
Journal:  World J Urol       Date:  2018-11-28       Impact factor: 4.226

3.  Importance of Assessing Compliance with Conservative Treatment of Primary Hyperoxaluria Type 1: A Case Report of a Patient with I244T/c.969-3C>G Mutation.

Authors:  Paloma Gutiérrez Medina; Laura Espinosa Román
Journal:  Perm J       Date:  2019-12-30

4.  Molecular analysis of the AGXT gene in Syrian patients suspected with primary hyperoxaluria type 1.

Authors:  Hossam Murad; Mohamad Baseel Alhalabi; Amir Dabboul; Nour Alfakseh; Mohamad Sayah Nweder; Youssef Zghib; Hala Wannous
Journal:  BMC Med Genomics       Date:  2021-06-03       Impact factor: 3.063

5.  Selected AGXT gene mutations analysis provides a genetic diagnosis in 28% of Tunisian patients with primary hyperoxaluria.

Authors:  Ibtihel Benhaj Mbarek; Saoussen Abroug; Asma Omezzine; Dorsaf Zellama; Abdellatif Achour; Abdelaziz Harbi; Ali Bouslama
Journal:  BMC Nephrol       Date:  2011-05-25       Impact factor: 2.388

6.  Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with primary hyperoxaluria type I.

Authors:  Elisa Oppici; Riccardo Montioli; Antonio Lorenzetto; Silvia Bianconi; Carla Borri Voltattorni; Barbara Cellini
Journal:  Mol Genet Metab       Date:  2011-10-05       Impact factor: 4.797

7.  Unusual clinical outcome of primary Hyperoxaluria type 1 in Tunisian patients carrying 33_34InsC mutation.

Authors:  Ibtihel Benhaj Mbarek; Saoussen Mdimeg; Amira Moussa; Dorsaf Zellama; Hayat Kaarout; Jaouida Abdelmoula; Abdellatif Achour; Saoussen Abroug; Asma Omezzine; Ali Bouslama
Journal:  BMC Nephrol       Date:  2017-06-15       Impact factor: 2.388

8.  Primary hyperoxaluria type 1 in 18 children: genotyping and outcome.

Authors:  Mohamed S Al Riyami; Badria Al Ghaithi; Nadia Al Hashmi; Naifain Al Kalbani
Journal:  Int J Nephrol       Date:  2015-03-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.